Difficult year for Biotechnology so far, down -17% YTD. Fundamentally the sector is gaining strength. Meaningful policy clarity to be achieved in 6-weeks based on election outcome. Biotechnology is ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...